Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT (DBT_dropout2)

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Study Overview

• Status: Completed
• Conditions: Borderline Personality Disorder; Psychotherapy; Dropout
• Intervention / Treatment: Behavioral: Dialectical Behavior Therapy

• Study Type: Observational
• Enrollment (Actual): 44

Contacts and Locations

Study Locations

• Germany
  • Bielefeld, Germany
    • Research Department

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

For this study, all patients aged from 18 to 65, discharged from our personality disorder inpatient unit between January 2019 and December 2021, and fulfilling three or more criteria for BPD as defined by DSM-IV (Borderline Personality characteristics; BPC) were considered (n = 44).

Description

Inclusion Criteria:

• three or more criteria for BPD as defined by DSM-5 (Borderline Personality characteristics; BPC)

Exclusion Criteria:

• inability to contract and consent,
• other severe mental disorders (bipolar disorder, acute psychosis),
• current alcohol,
• illicit or not prescribed drug use,
• simultaneous participation in other treatment studies,
• pregnancy or breastfeeding,
• an inability to negotiate a non-suicide agreement,
• ongoing traumatic contact with the perpetrator, and
• a Body Mass Index < 16.5.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Dialectical Behavior Therapy; The program's purpose is to help patients achieve the following therapeutic goals: (1) reduction of suicidal behaviors, (2) reduction of therapy-interfering behaviors, and (3) other risky or destabilizing behaviors. Standard DBT aims to achieve these goals by (1) conveying behavioral capabilities (skills), (2) motivation for applying these skills, (3) generalization of learned skills to the patient's natural environment, (4) structuring the treatment environment to reinforce functional behavior, and (5) conveying therapeutic resources and motivation to effectively treat patients with BPD.

Behavioral: Dialectical Behavior Therapy; DBT is a cognitive-behavioral treatment program that was developed to treat suicidal Patients with BPD (Linehan, 1993).

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Rate of Dropout	premature termination of treatment	8-10 weeks

Collaborators and Investigators

• Sponsor: Evangelisches Krankenhaus Bielefeld gGmbH

Study record dates

Study Major Dates

• Study Start (ACTUAL): January 1, 2019
• Primary Completion (ACTUAL): December 31, 2021
• Study Completion (ACTUAL): February 28, 2022

Study Registration Dates

• First Submitted: March 11, 2022
• First Submitted That Met QC Criteria: March 11, 2022
• First Posted (ACTUAL): March 21, 2022

Study Record Updates

• Last Update Posted (ACTUAL): April 1, 2022
• Last Update Submitted That Met QC Criteria: March 21, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Personality Disorders; Borderline Personality Disorder
• Other Study ID Numbers: DBT_dropout2

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No